ITEMS IN AFP WITH KEYWORD:
Nov 15, 2019 Issue
Gestational Hypertension and Preeclampsia: A Practice Bulletin from ACOG [Practice Guidelines]
Globally, hypertensive disorders of pregnancy are one of the main causes of maternal death. The American College of Obstetricians and Gynecologists has released a practice bulletin to outline diagnosis and treatment recommendations for these conditions.
RAS inhibitors, which include angiotensin receptor blockers, angiotensin-converting enzyme inhibitors, and renin inhibitors, should not be used as first-line agents.
Oct 1, 2019 Issue
Antihypertensive Drug Therapy for Mild to Moderate Hypertension During Pregnancy [Cochrane for Clinicians]
Compared with placebo, antihypertensive drug therapy for mild to moderate hypertension (defined by the authors as a blood pressure of 140 to 169 mm Hg systolic or 90 to 109 mm Hg diastolic) caused by chronic hypertension, gestational hypertension, or preeclampsia during pregnancy does not affect any pregnancy outcomes.
Key clinical questions and their evidence-based answers directly from the journal’s content, written by and for family physicians.
Mar 15, 2019 Issue
Coaching Patients About Successful Blood Pressure Management [Lown Right Care: Reducing Overuse and Underuse]
A collaboration between AFP and the Lown Institute promotes a vision of delivering heath care that is based on the evidence, balanced in its approach, and focused on the patient.
Despite the increasing prevalence and potential risks of hypertension in children, the diagnosis is often overlooked. Blood pressure should be measured annually beginning at three years of age, or at every visit if risk factors are present. Elevated blood pressure and hypertension in children is initially treated with lifestyle changes, although antihypertensives may be needed in some children.
Sep 1, 2018 Issue
Blood Pressure Targets for Patients with Hypertension and Cardiovascular Disease [Cochrane for Clinicians]
Achieving a target BP of 135/85 mm Hg or less does not decrease the risk of total cardiovascular events vs. treating to a target of 140 to 160/90 to 100 mm Hg. Further, treating to the lower BP target does not improve total mortality, cardiovascular mortality, or serious adverse effects.
Beginning antihypertensive treatment when the systolic blood pressure is greater than 140 mm Hg delays death and prevents major cardiovascular events in some persons without preexisting heart disease; in patients with existing heart disease, it prevents further events, but does not extend life.
The latest installment of the top 20 research studies for primary care physicians includes studies on cardiovascular disease and hypertension, infections, diabetes mellitus, musculoskeletal problems, and cancer screening, among other topics. The five highest-rated practice guidelines are also summarized.
The American Academy of Pediatrics (AAP) previously published guidance on screening for and managing high blood pressure (BP) in children and adolescents in 2004. An updated guideline was released by the AAP to address increased interest in childhood hypertension (HTN) and an updated search of the literature on the topic.